- Home
- GENC vs DERM Comparison
GENC vs DERM Comparison
Compare GENC & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENC | DERM |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.4M | 210.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GENC | DERM |
|---|---|---|
| Price | $13.53 | $8.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $16.00 | $12.67 |
| AVG Volume (30 Days) | 27.1K | ★ 142.2K |
| Earning Date | 12-09-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.92 | N/A |
| EPS | ★ 1.07 | N/A |
| Revenue | ★ $115,437,000.00 | $59,399,000.00 |
| Revenue This Year | N/A | $17.48 |
| Revenue Next Year | N/A | $55.83 |
| P/E Ratio | $12.66 | ★ N/A |
| Revenue Growth | 2.01 | ★ 2.82 |
| 52 Week Low | $10.80 | $3.86 |
| 52 Week High | $17.40 | $9.56 |
Technical Indicators
Market Signals| Indicator | GENC | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 53.07 |
| Support Level | $13.34 | $8.02 |
| Resistance Level | $14.13 | $9.56 |
| Average True Range (ATR) | 0.39 | 0.63 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 32.55 | 50.73 |
Price Performance
Historical ComparisonAbout GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.